the adult gut health [11] . Therefore, various commercial bifidobacteria have been developed and supplemented in many fermented dairy products. Interestingly, the clinical feeding study of commercial bifidobacteria revealed that they may not colonize and survive in the human intestinal environment, probably due to the strain attenuation by loss of competitive fitness against other intestinal bacteria during commercial fermentation [12] . To take advantage of the health-benefiting effects of bifidobacteria in the gut, B. longum BCBL-583 was newly isolated from a healthy Korean fecal sample and characterized by various evaluation tests to validate its probiotic effects, such as stress resistance tests, gut environment adaptation assays, and additional health promotion functions. This newly isolated and scientifically evaluated probiotic strain may be a good candidate for various food applications to enhance the gut health of Koreans.
To isolate Korean-oriented bifidobacteria, fourteen fecal samples were collected from healthy Koreans and 753 strains were selected and isolated using BIM-25 bifidobacteria selective medium [13] under anaerobic incubation at 37 o C for 24 h (data not shown). Among them, the strain BCBL-583 was selected by prescreening with simple oxygen tolerance test for further probiotic evaluation tests. To identify this strain, fructose-6-phosphate phosphoketolase (F6PPK) test [14] and 16S rRNA gene sequencing analysis with NCBI BLASTN program [15] were performed. Their results substantiated that this strain belongs to B. longum subsp. Longum (data not shown).
Bifidobacteria are one of the most important probiotics to endow the specific health promoting effects in fermented food products. However, food processing procedures are too tough for probiotics to survive in this condition. Therefore, stress tolerance activities are generally required for survival during food processing. The survival rate of the selected B. longum BCBL-583 was evaluated under oxygen and heat stress conditions. Oxygen tolerance test was conducted in two different ways with the incubation at 37 o C for 24 h: Static incubation on MRS agar plate without anaerobic condition and broth culture incubation with shaking at 60 or 120 rpm [16] . After incubation, numerous colonies were observed on the agar plates. In addition, the optical density of each broth culture was monitored at 595 nm wavelength (OD ). While initial OD 5 9 5 n m was 0.120 ± 0.02 at 0 h, it increased to 0.602 ± 0.07 at 60 rpm and 0.470 ± 0.06 at 120 rpm after 24 h shaking incubation, suggesting that B. longum BCBL-583 has oxygen tolerance activity (Fig. 1A) . In addition, a heat tolerance test was performed as a previously published protocol [17] : (1) anaerobic incubation for 12 h (2) heat shock at 42°C, 45°C, and 60°C for 3 h, respectively (3) recovery at 37°C for 12 h (4) determination of absorbance at 595 nm wavelength. While >99% of BCBL-583 was recovered after both 42 C. This result suggests that it is stable and heattolerant even at long-term heat stress conditions, indicating that it may be suitable for further commercial applications (Fig. 1B) .
To survive in the human intestinal environment, gastric acid/bile salt tolerance and mucin layer adhesion may be important. Therefore, gastric acid/bile salt tolerance and mucin adhesion activities of BCBL-583 were determined. Gastric acid/bile salt test were conducted using a previously published procedure [18] : (1) bile salt exposure at 37°C for 3 h (2) PBS washing (3) gastric acid exposure at 37°C for 3 h (4) viable cell count after incubation on MRS agar plate at 37°C for 24 h. The survival rate of BCBL-583 was 85.79 ± 1.53% in gastric acid/bile salt, which is similar to type strains, B. longum ATCC 15707 and 15708 ( Fig. 2A) . This result indicates that BCBL-583 may survive in the passages of the stomach and intestinal environments. In addition to survival in the digestive organs, adhesion to mucin surface layers is also important for colonization and propagation of bifidobacteria in the intestinal environment. After attachment of mucin (Sigma, Germany) on the surface of 96-well plates at 4°C for 12 h, BCBL-583 cells were added to the plate and incubated at 37° C for 3 h. The number of attached cells was determined with difference between viable cell number in the control culture and detached viable cell number in the PBS buffer after washing [17, 19] . The attachment rate of B. longum BCBL-583 was 73.72 ± 7.36%, which is a higher rate than that of ATCC 15707 (58.99 ± 16.65%), but a lower rate than that of ATCC 15708 (82.08 ± 14.22%) (Fig. 2B) . This result suggests that BCBL-583 can survive during the passage of digestive organs and colonize in the mucosal cell surface layer of the human gut.
Because it is known that accumulation of excessive cholesterol in the blood stream may cause cardiovascular disease, concentration of cholesterol needs to be controlled. Interestingly, it was previously reported that bifidobacteria can assimilate cholesterol into their cell membranes [20] . To evaluate the cholesterol lowering activity of BCBL-583, it was cultured with 250 mM cholesterol in MRS broth medium and incubated at 37 o C for 24 h. After incubation, the remaining cholesterol in the culture was determined using Total Cholesterol Assay Kit (Cell Biolabs Inc., USA). This result showed that B. longum BCBL-583 lowered up to 86.31 ± 1.85% of cholesterol in the culture, indicating its cholesterol lowering activity (Fig. 3) . In addition, culture supernatant of BCBL-583 showed anti-Helicobacter pylori activity (diameter of inhibition zone, 16 ± 0.0 mm), comparing 15 mg/ml lactoferrin as a positive control (18.5 ± 2.12 mm) [21] , suggesting that it can inhibit the growth of H. pylori. Furthermore, gut immune stimulation activity of BCBL-583 was determined using Caco-2 cells. To evaluate this activity, 10 8 CFU/ml of viable or dead BCBL-583 cells were added to Caco-2 cell culture and incubated for 24 h. After incubation, TNF-α, IL-6, IL-8, and IL-10 of Caco-2 cell culture supernatants were quantified using ELISA kit (Komabiotech, South Korea). These cytokines were mainly secreted by dead BCBL-583 cells (TNF-α, 10.55 ± 6.00 pg/ml; IL-6, 4.44 ± 2.76 pg/ml; IL-8, 44.28 ± 3.89 pg/ml; IL-10, 6.11 ± 1.7 pg/ml), suggesting that BCBL-583 has immune stimulation activity. Subsequent immune response assay with RAW 264.7 macrophage cells and dead BCBL-583 cells (10 8 CFU/ml) substantiated this activity (TNF-α, 57.32 ± 5.96 pg/ml; IL-6, 16.08 ± 3.7 pg/ml).
Therefore, the new probiotic strain, B. longum BCBL-583 revealed all required properties regarding survival and colonization abilities in the human gut environment as well as probiotic effects including cholesterol reduction, anti-H. pylori activity, and gut immune stimulation, suggesting that it can be a good candidate as a new probiotic strain of bifidobacteria for further probiotic applications in food industries. The GRAS (Generally Recognized As Safe) state of BCBL-583 support this. However, further in vivo evaluation tests of this strain to overcome various hurdles 
